联系人：李经理
手机：18116171568
邮箱：lgj@theramabs.com
地址：上海浦东新区惠南镇东征路133号
网址：www.Theraprotein.com
Product Name：Ranibizumab |
Introduction: |
This product is the biosimilar of Ranibizumab (347396-82-1), which is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. The biosimilar binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A), which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium. *Statement: this product is used for R&D and IND only, not for clinical and commercial usage before registered in drug registration authority. |
Features and Advantages: |
| NameRanibizumabCAS NO.347396-82-1TypeFab fragmentSourceHumanized (from mouse)TargetVEGF-ACloneMonocloneMolecular Weight48 kDaFormulaC2158H3282N562O681S12Antibody FormPurified immunoglobulinPhysical FormSolutionPlace of OriginUSAStorageSealed and stored at -70±15℃, away from light |
Specifications: |
The Ranibizumab is supplied at 2mg/tube, 5mg/tube, 10mg/tube, 20mg/tube as a sterile, clear and colorless, preservative-free solution. |
Quality Assurance： |
(1) We have advanced technology and equipment to satisfy the requirements of GMP. All the raw material purchasing and production quality control are strictly following the ISO9001. (2) We own a group of QCs with rich experience, mainly engaging in testing APIs, intermediates and finished products. Before posting, all of the stuffs must receive professional training and GMP courses. (3) The COA(Certificate of Analysis), MOA(Method of Analysis), SDS(Stability Data Sheet), DMF(Drug Master File) and MSDS(Material Safety Data Sheet) are available. |